10 results on '"MacConell L."'
Search Results
2. Three years of obeticholic Acid (OCA) therapy results in histological improvements in patients with primary biliary cholangitis: further analysis of the POISE Biopsy substudy.
3. PC.01.8 THE AESOP TRIAL: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDY OF OBETICHOLIC ACID IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS.
4. Durable response in the markers of cholestasis through 36 months of open-label extension with obeticholic acid in Italian patients with primary biliary cholangitis.
5. PC.01.3: Efficacy and Safety of Obeticholic Acid in Patients with Primary Biliary Cholangitis: An Analysis of the Italian Patients from a Phase 3, Randomized, Placebo-Controlled Study.
6. Durable response in the markers of cholestasis through 24 months of open-label extension with obeticholic acid in Italian patients with primary biliary cholangitis.
7. Durable response in the markers of cholestasis through 18 months of open-label extension with obeticholic acid in primary biliary cholangitis.
8. OC.12.8 LONG-TERM SAFETY OF OBETICHOLIC ACID IN PATIENTS WITH PRIMARY BILIARY CIRRHOSIS.
9. OC.06.8 INTEGRATED ANALYSIS OF EFFICACY OF PHASE II AND III DATA OF OBETICHOLIC ACID IN PBC SUBPOPULATIONS BASED ON AGE AND SEX.
10. OC.06.1 ANALYSIS OF THE EFFICACY OF OCA IN PRIMARY BILIARY CIRRHOSIS BY VARYING PATIENT DISEASE SEVERITY ACROSS THREE RANDOMIZED DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIALS.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.